Mathias Oelke Nex Immune, Inc. (NEXI) insider trading activity
Mathias Oelke is Chief Science Officer of NexImmune, Inc.. Currently has a direct ownership of 134,023 shares of NEXI, which is worth approximately $40,206. The most recent transaction as insider was on Nov 22, 2022, when has been sold 126,100 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
134K
0%
3M change
0%
12M change
Total Value Held
$40,206
MO
Mathias Oelke
Chief Science Officer
Gaithersburg, MD